WASHINGTON, Feb. 8, 2018 /PRNewswire/ — 60 Degrees Pharmaceuticals (60P) received Priority Review Designation from the United States Food and Drug Administration (USFDA) for Tafenoquine (TQ) for prevention of malaria in adults. The FDA…Original Article
60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria Drug
